✦ LIBER ✦

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

✍ Scribed by Byrd, John C.; Brown, Jennifer R.; O'Brien, Susan; Barrientos, Jacqueline C.; Kay, Neil E.; Reddy, Nishitha M.; Coutre, Steven; Tam, Constantine S.; Mulligan, Stephen P.; Jaeger, Ulrich; Devereux, Steve; Barr, Paul M.; Furman, Richard R.; Kipps, Thomas J.; Cymbalista, Florence; Pocock, Christopher; Thornton, Patrick; Caligaris-Cappio, Federico; Robak, Tadeusz; Delgado, Julio; Schuster, Stephen J.; Montillo, Marco; Schuh, Anna; de Vos, Sven; Gill, Devinder; Bloor, Adrian; Dearden, Claire; Moreno, Carol; Jones, Jeffrey J.; Chu, Alvina D.; Fardis, Maria; McGreivy, Jesse; Clow, Fong; James, Danelle F.; Hillmen, Peter

Book ID: 127258657
Publisher: Massachusetts Medical Society
Year: 2014
Tongue: English
Weight: 660 KB
Volume: 371
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa1400376

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ofatumumab and bendamustine in previousl

Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma

✍ Ujjani, Chaitra; Ramzi, Pari; Gehan, Edmund; Wang, Hongkun; Wang, Yiru; Cheson, 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 350 KB

**102 Chemoimmunotherapy with Ofatumumab

**102 Chemoimmunotherapy with Ofatumumab, Fludarabine and Cyclophosphamide (O-FC) in Previously Untreated Patients with Chronic Lymphocytic Leukemia

✍ William G. Wierda; Thomas J. Kipps; Jan Dürig; Laimonas Griskevicius; Stephan St 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 179 KB

5.15 Resistance to Complement-Dependent

5.15 Resistance to Complement-Dependent Cytotoxicity in Chronic Lymphocytic Leukemia Cells from Patients Treated with Ofatumumab

✍ Nisar A. Baig; Ronald P. Taylor; Margaret A. Lindorfer; Amy K. Church; Betsy R. 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 217 KB

Rapid complete donor lymphoid chimerism

Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia

✍ Shaffer, Brian C.; Modric, Marko; Stetler-Stevenson, Maryalice; Arthur, Diane C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 522 KB

Protection from apoptotic cell death by

Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients

✍ Oskar S. Frankfurt; John J. Byrnes; Luis Villa 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 703 KB

A phase I study of imatinib mesylate in

A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients

✍ Jonathan Hebb; Sarit Assouline; Caroline Rousseau; Pierre DesJardins; Stephen Ca 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 325 KB